Fund shareholders of IGC PHARMA INC
ISIN US45408X3089 · United States · LEI 529900TIWO8H06FQC983
- Fund shareholders
- 5
- Of which ETFs
- 1 4 other funds
- Value held
- 644.2K $
- Share of capital
- 2.2 % of 103.4M shares on Aug 5, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 814,914 | 221.7K $ | 0.00 % | 0.79 % | as of Jun 30, 2026 ↗ |
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 678,480 | 184.5K $ | 0.42 % | 0.66 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 630,022 | 182K $ | 0.00 % | 0.61 % | as of May 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 98,554 | 28.5K $ | 0.10 % | as of May 31, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 95,369 | 27.6K $ | 0.09 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 0.42 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 5 | +1 | 2,317,339 | +69.4 % |
| 2026Q2 | 4 | 0 | 1,367,848 | -0.3 % |
| 2026Q1 | 4 | 0 | 1,371,966 | +5.6 % |
| 2025Q4 | 4 | 0 | 1,299,693 | +6.8 % |
| 2025Q3 | 4 | 0 | 1,216,871 | +1.9 % |
| 2025Q2 | 4 | 0 | 1,194,388 | -0.9 % |
| 2025Q1 | 4 | 0 | 1,205,554 | +17.8 % |
| 2024Q4 | 4 | 0 | 1,023,032 | +9.2 % |
| 2024Q3 | 4 | 0 | 936,679 | +1.1 % |
| 2024Q2 | 4 | -1 | 926,917 | -7.1 % |
| 2024Q1 | 5 | 0 | 997,365 | +2.2 % |
| 2023Q4 | 5 | 975,508 |
Institutional managers
32 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 1,043,384 | 274.4K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 703,798 | 185.1K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 483,975 | 127.3K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 200,799 | 52.8K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 122,595 | 32.2K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 113,407 | 29.8K $ | as of Mar 31, 2026 |
| LAWOOD & CO | 75,000 | 19.7K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 65,541 | 17.2K $ | as of Mar 31, 2026 |
| DEARBORN PARTNERS LLC | 59,401 | 15.6K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 50,648 | 13.3K $ | as of Mar 31, 2026 |
| Fisher Asset Management, LLC | 43,400 | 11.4K $ | as of Mar 31, 2026 |
| TRUIST FINANCIAL CORP | 36,667 | 9.6K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 35,118 | 9.2K $ | as of Mar 31, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | 33,848 | 8.9K $ | as of Mar 31, 2026 |
| Virtu Financial LLC | 23,233 | 6 $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 21,049 | 5.5K $ | as of Mar 31, 2026 |
| T3 Companies, LLC | 20,000 | 5.3K $ | as of Mar 31, 2026 |
| Schneider Downs Wealth Management Advisors, LP | 10,000 | 2.6K $ | as of Mar 31, 2026 |
| HighTower Advisors, LLC | 10,000 | 2.6K $ | as of Mar 31, 2026 |
| Wealthcare Advisory Partners LLC | 10,000 | 2.6K $ | as of Mar 31, 2026 |
| UBS Group AG | 8,097 | 2.1K $ | as of Mar 31, 2026 |
| Trask Adam Roland | 5,000 | 1.3K $ | as of Mar 31, 2026 |
| GROUP ONE TRADING LLC | 3,762 | 989 $ | as of Mar 31, 2026 |
| Geneos Wealth Management Inc. | 3,000 | 780 $ | as of Mar 31, 2026 |
| CWM, LLC | 1,000 | 263 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of IGC PHARMA INC". https://titelia.com/en/stocks/igc-pharma-inc-US45408X3089